Researchers from the Cardiac & Vascular Institute at NYU Langone Medical Center will present at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium on September 21-25, 2010 in Washington, DC. They will be available for interviews during the conference.
Louis Miller, MDInterventional Cardiology Fellow, Department of Medicine, Leon H. Charney Division of Cardiology at NYU Langone Medical Center
Wednesday, September 22, 2010
Presenter•Very Long-term Clinical Follow-up After Fractional Flow Reserve-Guided Coronary Revascularization, 1:00pm
Embargoed Abstract - September 22, 1:00pm:This study followed approximately 150 patients over the last decade, who underwent cardiac catheterization and were found to have angiographically significant coronary lesions that were borderline in severity. A technique called fractional flow reserve (FFR) was used to determine the physiologic significance of these lesions, and guide decisions regarding whether to revascularize these lesions with stents or surgery, or to treat with medical therapy alone. Researchers determined that there was no difference in adverse events including excess mortality, cardiac death, heart attack, need for later revascularization, or angina in patients who underwent FFR-guided revascularization at that time versus those that did not. Researchers believe this is the longest clinical follow-up of patients undergoing FFR-guided revascularization to date. An FFR-guided approach to coronary stenoses of borderline severe lesions is safe and effective over a period of at least 10 years, and has no excess risk of angina, need for further revascularization, heart attacks, or death. This study was done in collaboration with The Manhattan VA.
Judith S. Hochman, MDHarold Snyder Family Professor of Cardiology, Clinical Chief, Leon H. Charney Division of Cardiology and Director, Cardiovascular Clinical Research Center at NYU Langone Medical Center
Thursday, September 23, 2010
Moderator•Coronary Revascularization Decisions -Building on COURAGE, SYNTAX and BARI-2D, 2:00pm to 6:00pm
Lecturer•Focus on Ischemia: The ISCHEMIA Trial Design, 2:52pm
Moderator•Difficult Patients and Dilemmas in Interventional Cardiology- Session IV: Too Many Coronary Angiograms and/or Not Enough Stress Tests?, 4:31pm to 5:28pm
Lecturer•Current Recommendations for Revascularization in Asymptomatic or Minimally Symptomatic, Patients and Multivessel Disease, 5:28pm
Frederick Feit, MD,Associate Professor, Department of Medicine, Leon Charney Division of Cardiology and Director of Interventional Cardiology Training Program at NYU Langone Medical Center, and Director, Cardiac Catheterization and Interventional Cardiology at Bellevue Hospital
Thursday, September 23, 2010
Moderator•Diabetes and Cardiovascular Disease: 2010 Update, 12:15 pm to 1:55 pm
Lecturer•Antithrombotic and Antiplatlet Therapy in ACS and Diabetes, 1:27 pm
Lecturer•Glass Overflowing: Even with its Limitations, BARI-2D Supports Revascularization in Most Diabetic Patients, 3:33 pm
Friday, September 24, 2010
Lecturer•Tough Calls in the Cath Lab: Case-Based Reviews - Coronary Anomalies, 8:30 am
Source: NYU Langone Medical Center / New York University School of Medicine